Our Team and Experience
Our associates have worked in the pharmaceutical industry in the areas of Regulatory Affairs, Quality Assurance, Pharmaceutical Development, Logistics and Pharmacovigilance, providing IRIS Global with vast experience in the pharmaceutical industry for more than 20 years and have helped multinational companies to go through the confused system of INVIMA. Our team at COLOMBIA is a young company formed by experienced pharmacists who have supported and advised multinational companies such as AstraZeneca, Eli Lilly and Company, Merck, Hospira, Schering Plow, and Novartis.
Along with our partners we have over 40 years of experience in areas such as: quality control, validation, export / import, R&D, regulatory affairs (Mexico and Latin America) and pharmacovigilance.
COLOMBIA has managed and assisted companies in the development and implementation of international policies for SAP, BPCS, Trackwise, change of control systems, product development and filing.
With its experience and expertise IRIS Global partners can offer you innovative solutions for your company.
|
INVIMA
INSTITUTO NACIONAL DE VIGILANCIA DE MEDICAMENTOS Y ALIMENTOS
Headquarters:
Carrera 10 # 64 - 28 Bogota, Colombia
Phone: +57-(1) 2948700
Nit 830.000.167-2
With the issuance of Law 100 of 1993 the "General System of Social Security in Health" was created, which changed and reorganized the provision of health services and integrated public health, the social security system and the provision of private services.
Among the transcendental decisions set forth in this standard, article 245 ordered the creation of the National Institute of Food and Drug Surveillance INVIMA. In execution of this mandate in 1994 the Decree 1290 was issued, by means of which the functions of INVIMA were defined and its basic organization established. It was then defined as the nature of INVIMA to be a public institution of the national order, of a scientific and technological nature, with legal personality, administrative autonomy and independent patrimony, belonging to the Health System and subject to the general provisions that regulate its operation.
With the issuance of Law 100 of 1993 the "General System of Social Security in Health" was created, which changed and reorganized the provision of health services and integrated the public health, the social security system and the provision of private services. Among transcendental decisions set forth in this norm, article 245 ordered the creation of the National Institute of Food and Drug Surveillance INVIMA. Then Decree 1290 was issued in 1994, by means of which the functions of INVIMA were defined and its basic organization was established. Since then INVIMA has been a national public institution of a scientific and technological nature, with legal personality, administrative autonomy and independent patrimony, belongs to the Health System and is subject to the general provisions that regulate its operation.
Due to the institutional commitment in 2009 INVIMA received recognition from the Pan American Health Organization as the National Regulatory Authority for Medicines in Latin America and in 2010 the Icontec certification under the NTC GP 1000: 2009 and ISO 9001: 2008 norms. Today, INVIMA makes important efforts to strengthen its presence throughout the national territory, modernize its organizational structure, spread out its infrastructure and to be recognized at international level as a technical and scientific reference in matters within its competence.
|
